Immune cell therapy with an approach to concepts, products and quality systems is the title of the symposium held for the fourth time to evaluate new cancer treatment methods. The use of immune cell therapy in treatment of cancers is the basis of immune cell therapy.

The symposium will be held by the stem cells technologies development headquarter at Children"s Medical Center on February 6^th, 2020.

Market and challenges in immune cell-based therapies, quality system requirements and research and development, ethics in TB immunotherapy and therapeutic applications and therapeutic products of CAR-T Cell, NK Cell, DC are the topics of the event.

Scholars and researchers are familiarized with the concepts, products, and quality system of immunotherapy in this event. In addition, the presence of policymakers in this symposium provides an appropriate context for the interest and activity of those interested in promoting this field. This symposium will be held with the participation of clinical and basic science professors from different universities to study this issue clinically and practically.

In general, immune cell therapy is approach to cancer treatment, which has received much attention due to the research conducted in the field and the results obtained from clinical trials. It has also recently been used widely as a bridge between routine treatments and bone marrow transplantation in patients requiring bone marrow transplantation.

Children"s Medical Center of Tehran University of Medical Sciences and the stem cells technologies development headquarter will hold the event in cooperation with other centers to familiarize various groups such as physicians and researchers with the field.

A report by the public relations and information center of the Vice-Presidency for science and technology affairs